FindTrial
Sign In

A study of gynaecological health issues in women with rare inherited bleeding disorders

A prospective analysis of gynaecological health issues in women with rare inherited bleeding disorders - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/086152
Enrollment
50
Registered
2025-05-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D682- Hereditary deficiency of other clotting factors

Interventions

Intervention1: NIL: NIL

Sponsors

Dr Aashima Arora
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Females from menarche(~12) to 45 years with diagnosed rare inherited bleeding disorders will be recruited.

Exclusion criteria

Exclusion criteria: females while pregnant or upto 6 months postpartum, women who have undergone hysterectomy due to any indication prior to recruitment in study

Design outcomes

Primary

MeasureTime frame
to study the menstrual patterns and prevalence of heavy menstrual bleeding in women with rare inherited bleeding disordersTimepoint: at baseline—

Secondary

MeasureTime frame
To study the pattern of hormonal interventions (LNG-IUS, OCPs, Progesterone only pills) utilised in addition to haemostatic therapy & their efficacy in the management of HMB, To study the prevalence of other gynaecologic issues(endometriosis, haemorrhagic ovarian cyst & dysmenorrhea) in women with RBD,To assess the psychosocial impact of gynaecological health issues in women with RBD using qualitative methods.Timepoint: 3 months—

Countries

India

Contacts

Public ContactMuskan Aggarwal

Post Graduation Institute of Medical Education and Research,

aashicool84@gmail.com9915501844

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026